Cargando…
Rapamycin reverses insulin resistance (IR) in high-glucose medium without causing IR in normoglycemic medium
Mammalian target of rapamycin (mTOR) is involved in insulin resistance (IR) and diabetic retinopathy. In retinal pigment epithelial (RPE) cells, insulin activates the mTOR pathway, inducing hypoxia-inducible factor-1α (HIF-1α) and HIF-dependent transcription in serum-free minimum essential medium Ea...
Autores principales: | Leontieva, O V, Demidenko, Z N, Blagosklonny, M V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047870/ https://www.ncbi.nlm.nih.gov/pubmed/24810050 http://dx.doi.org/10.1038/cddis.2014.178 |
Ejemplares similares
-
Elimination of Proliferating Cells Unmasks the Shift from Senescence to Quiescence Caused by Rapamycin
por: Leontieva, Olga V., et al.
Publicado: (2011) -
Resveratrol potentiates rapamycin to prevent hyperinsulinemia and obesity in male mice on high fat diet
por: Leontieva, O V, et al.
Publicado: (2013) -
While reinforcing cell cycle arrest, rapamycin and Torins suppress senescence in UVA-irradiated fibroblasts
por: Leontieva, Olga V., et al.
Publicado: (2017) -
Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to
por: Blagosklonny, Mikhail V.
Publicado: (2012) -
Weekly administration of rapamycin improves survival and biomarkers in obese male mice on high-fat diet
por: Leontieva, Olga V, et al.
Publicado: (2014)